Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

RAGE-ligand axis: A new biomarker in multiple sclerosis, time for multicentre validation study!
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.
2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency suppresses central nervous system damage in a murine MOG-induced multiple sclerosis model.
Screening and characterization of molecules that modulate the biological activity of IFNs-I.
Regulating Axonal Responses to Injury: The Intersection between Signaling Pathways Involved in Axon Myelination and The Inhibition of Axon Regeneration.
Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells.
Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.
Adipose-Derived Stem Cells Enhance Axonal Regeneration through Cross-Facial Nerve Grafting in a Rat Model of Facial Paralysis.
Qualitative exploration of the benefits of group-based memory rehabilitation for people with neurological disabilities: implications for rehabilitation delivery and evaluation.
Imaging of noninfectious inflammatory disorders of the spinal cord.
Multiple sclerosis: Biomarkers and genetic variants reflect disease course in multiple sclerosis.
"Gadolinium-Phobia:" Not a Helpful "Criterion" for Indication for Gadolinium-based Contrast Agent Administration in Multiple Sclerosis.
Delayed iron deposit and atrophy of the putamen in a case with osmotic demyelination syndrome.
Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.
Response on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.
Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G.
Increasing Physical Activity and Participation in People with Multiple Sclerosis: A Review.
A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.
Are electrophysiological criteria useful in distinguishing childhood demyelinating neuropathies?
From Natural Product to the First Oral Treatment for Multiple Sclerosis: The Discovery of FTY720 (Gilenya™)?
Loss of Hippocampal Oligodendrocytes Contributes to the Deficit of Contextual Fear Learning in Adult Rats Experiencing Early Bisphenol A Exposure.
Insulin influenced expression of myelin proteins in diabetic peripheral neuropathy.
Regional Myelin and Axon Damage and Neuroinflammation in the Adult Mouse Brain After Long-Term Postnatal Vanadium Exposure.
Gut microbiome analysis in neuromyelitis optica reveals over-abundance of Clostridium perfringens.

Pages